The eyes are a window to the brain – and this outward extension of the central nervous system may reveal early signs of ...

Children with albinism and visual impairment demonstrate better visual search performance than other children with other visual impairments.

At 2 years, Black and white patients who received Lucentis for the treatment of diabetic macular edema achieved similar ...

Did Caitlin Clark play tonight vs Las Vegas Aces? No, the Fever star missed has been ruled out for the season with a right groin injury. What is Indiana Fever's record? The Fever were 24-20 in the ...

Which central Ohio high school football teams won in the first round of the OHSAA playoffs? See the scores below, and check out our live blog for coverage of Dublin Jerome at Hilliard Bradley, Grove ...

The company describes KSI-101 as a “novel, potent, and high-strength (100 mg/mL) antibody-based investigational therapy with ...

D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuity, control of retinal anatomy and reduction of treatment burden at all ...

Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today follow-up ...

AXPAXLI (TM) (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...

SOL-R, the second registrational trial of AXPAXLI™ in wet AMD, remains on track for topline data in 1H 2027Together with SOL-1, these ...

Cash balance of $344.8 million as of September 30, 2025, together with net proceeds of ~$445 million from October 2025 equity offering, with expected runway into 2028 BEDFORD, Mass., Nov. 04, 2025 ...

Research and development expenses for the third quarter of 2025 were $52.4 million versus $37.1 million for the comparable quarter in 2024, reflecting an increase in overall clinical expenses ...